Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / TAK - The Prognosis For Phathom Pharmaceuticals

TAK - The Prognosis For Phathom Pharmaceuticals

Takeda Pharmaceutical Company Limited American Depositary Shares
  • Today, we put Phathom Pharmaceuticals in the spotlight for the first time.
  • The company just got one FDA approval and is in the process of garnering another for its primary drug candidate vonoprazan.
  • The drug is licensed from Takeda and has seen impressive sales in Japan. An investment analysis follows in the paragraphs below.

For further details see:

The Prognosis For Phathom Pharmaceuticals
Stock Information
Company Name: Takeda Pharmaceutical Company Limited American Depositary Shares
Stock Symbol: TAK
Market: NYSE
Website: takeda.com
Menu
TAK TAK Quote TAK Short TAK News TAK Articles TAK Message Board
Get TAK Alerts

News, Short Squeeze, Breakout and More Instantly...